J Korean Neurosurg Soc.
1990 May;19(5):646-653.
Stereotatic Interstitial Brachytheraoy with Iridium-192 in the Treatment of Brain Tumors-Report of Intial Experience
- Affiliations
-
- 1Department of Neurosurgery, Korea Cancer Center Hospital, Seoul, Korea.
- 2Department of Therapeutic Radiology, Korea Cancer Center Hospital, Seoul, Korea.
Abstract
- Five patients with brain tumors have been treated with an afterloaded removable Iridium-192 interstitial brachytherapy using Brown-Roberts-Wells stereotactic system. There were two cases of glioblastoma multiforme, one case of recurrent glioblastoma multiforme, one case of recurrent metastatic brain tumor and one case of recurrent astrocytoma grade II. The patients were treated by combination of surgery or stereotactic biopsy and external radiation previously. Tumor doses ranging from 4100 to 8600 cGy were delivered to these patients. There was no death and 4 patients showed definite tumor regression 3 months following interstitial brachytherapy. The method was safe and appeared to be effective madality to achieve local control of brain tumors.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Analysis of Stereotactic Brachytherapy with High-Activity Iridium-192 Sources for Treatment of Malignant Astrocytomas
- Clinical Analysis of Brachytherapy Using Iodine-125 and Iridium-192 for the Treatment of Intracranial Malignant Gliomas
- Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources
- Scalp Metastasis of Glioblastoma Multiforme after Craniotomy and stereotatic Interstitial Brachytherapy
- Brachytherapy in the Treatment of Head and Neck Cancer
